Delivery Order SPE2DB24D2205-SPE2DB25FEEDB
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trokendi XR 100 mg capsules. The contract has a ceiling value of $1,949.13 and an ultimate completion date of February 2, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Trokendi XR 200 mg capsules, with a ceiling value of $3,366.60 and an ultimate completion date of May 13, 2024. The contract type is Firm Fixed Price. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trokendi XR 50 MG capsules, a prescription medication, with a ceiling value of $14,985.85 and a performance period ending on July 14, 2025. The contract is a firm-fixed-price delivery order, indicating a pre-determined price for the pharmaceutical product. This contract is not designated as a set-aside,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,347.76 and is for the delivery of Trokendi XR 25 mg capsules. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of March 19, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This federal contract award, valued at $1,851.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 100 mg capsules, a specialty medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 20, 2024. The contract is not designated with a set-aside requirement, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trokendi XR 25 mg capsules and has a ceiling value of $2,121.13. The contract is a firm fixed-price, non-set-aside award with a period of performance ending on May 20, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 100 mg capsules, a neurological medication, with a ceiling value of $2,402.82 and a period of performance through June 5, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,262.75, is for the delivery of Trokendi XR 50 mg capsules. The contract has an ultimate completion date of July 3, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trokendi XR 100 mg capsules. The contract has a firm fixed price of $3,423.10 and a completion date of June 12, 2025. The contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) vehicle that AmerisourceBergen holds with the DLA Troop Support Medical, which provides comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the provision of Trokendi XR 100 mg capsules. The contract has a ceiling value of $3,843.93 and will run through August 29, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEDBDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trokendi XR 200 mg capsules. The contract has a ceiling value of $5,480.96 and a performance period extending through June 27, 2025. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs and other government agencies. This delivery order contract is part of the company's broader federal contract portfolio, demonstrating its capacity to fulfill diverse medical supply requirements for the U.S. government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 6/26/25 |